Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,993 total articles
AAR (AIR) has shown the first clear signs of backlog translating into recurring revenue and profit. Strong recent quarters, accelerating sales, and improving margins—combined with a healthy balance sheet and a growing MRO market—support a tactical long. This trade idea lays out entry, stop, and tiered targets with risk controls and catalysts to wat…
We upgrade Kingsoft Cloud (KC) to BUY with a $22 target. Market cap is $3.22B and recent data show accelerating AI cloud growth, improving margins and bullish technicals. A capital-efficient shift to GPU-centric AI engines and tighter cost control should drive EBITDA leverage; the trade is actionable ahead of the Q2 2026 print with a clear entry, s…
Luckin Coffee (LKNCY) is a different animal than Starbucks. Fast-store expansion, technology-first unit economics and strong customer growth give the stock room to appreciate from $32.09. I recommend a tactical long: enter at $32.00, stop at $29.00, target $39.00 over a swing window as the market re-rates growth to profitability.
Kraken Robotics (KRKNF) designs sonar, subsea batteries and underwater robotic systems that are landing repeat naval and infrastructure contracts. With a $1.64B market cap and accelerating revenue (Q1 revenue jumped to $21M, +175% YoY), the story is now about converting program wins into scale. This is a tactical long: enter near $4.25, protect cap…
Coherent (COHR) is a prime supplier of optical components, lasers and engineered materials to the AI and data-center upgrade cycle. Fundamentals and secular demand remain intact, but the stock has suffered a heavy pullback on broader multiple compression and volatile flows. We keep a Buy stance because the long-term thesis still works; the trade he…
AnaptysBio has cleared a meaningful procedural hurdle in its fight with Tesaro/GSK and has moved the litigation closer to a definitive outcome. With a $1.54B market cap, modest free cash flow and a compact float, the stock is positioned for a sharp re-rate if Anaptys secures reversion or damages tied to Jemperli royalties. This trade idea lays out …
Gentex (GNTX) is a cash-flowing, low-debt auto supplier trading at mid-teens earnings multiples and an EV/EBITDA under 8. For traders willing to accept leverage and a wider stop, a mid-term swing long at $24.05 targets $28.50 with a $20.80 stop - a plan that leans on solid fundamentals, recent sales uplift from acquisition, and high short interest …
Interface is executing: steady top-line growth, margin recovery, and cash generation combined with product innovation (LVT, Intersept) support a tactical long. Valuation is reasonable at roughly $2.04B market cap and a mid-teens P/E. Trade plan below sets an entry at $34.45, a stop at $31.50, and a near-term target at $38.00 for a mid-term (45 trad…
Navios Maritime Partners has captured meaningful tanker arbitrage upside and the stock is trading near its 52-week high. With a market cap of about $2.46B and a P/E of ~6.3, the company looks cheap on headline metrics, but the next leg higher depends on capital allocation: debt paydown vs buybacks vs distributions. Our trade sets a clear entry at $…
Novavax is a beaten-down vaccine specialist trading near oversold technicals and a sub-$1.3B enterprise value. Recent adjuvant licensing and sector momentum give a plausible re-rating catalyst over the next 45 trading days, but inconsistent revenue, cash burn, and heavy short interest make this a pragmatic, risk-managed trade.
Uber fell into a deep pullback recently; at current levels the company trades at mid-teens earnings multiple with $9.1B in free cash flow and a $144B market cap. I’m adding to my position with a position-sized buy, a tight stop below the recent low, and a target that prices in recovery in mobility and delivery margins. This is a trade for investors…
Coca-Cola (KO) reported strong Q2 results and raised full-year guidance, hitting an all-time high intraday. For traders looking to shift out of headline-driven tech volatility, KO offers a liquid, dividend-paying defensive play with room to run on continued volume recovery and margin tailwinds. This idea lays out a concrete entry, stop and target f…
argenx's VYVGART franchise is entering a new phase after broad FDA label expansion and encouraging CIDP data. With a $56.9B market cap, a clear path to multi-billion dollar sales, and improving trial dynamics across neuromuscular indications, the risk/reward favors buying weakness. This trade idea lays out an entry, stop, and target for a long-term…
HubSpot has been hammered in 2026 amid broad SaaS volatility and cornered narratives around AI. The business is still growing 23% year-over-year, generates ~$743M of free cash flow and serves ~300,000 customers. At $238 the stock is a tactical buying opportunity for a 180-trading-day recovery to healthier multiples. Trade plan included.
Telkom Indonesia (TLKM) looks poised to re-rate after a string of positive operational updates: steady broadband subscriber growth, faster-than-expected migration to fixed broadband and 5G-capable customers, and clearer capital allocation priorities from management. We move to a bullish stance and recommend a tactical long with defined entry, stop,…
COMPASS Pathways (CMPS) is a leading pure-play psilocybin biotech that has gone from speculative to clinical-leader status after two positive Phase 3 readouts and favorable regulatory movement. With a market cap near $1.46B, meaningful cash on hand, and continued short interest that can amplify moves, this trade targets a retest of prior highs whil…
LATAM (LTM) will report through a bumpy Q2 operationally, but shares trade at a modest P/E and sit closer to cycle lows than highs. This trade idea buys a tactical dip around current levels with a defined stop and ambitious but realistic target tied to passenger recovery and margin normalization over the next 45 trading days.
Kopin (KOPN) is a small-cap microdisplay and wearable optics specialist trading at $3.53. Recent demand drivers in AR/VR, defense training, and industrial metrology plus an elevated short interest create a favorable risk/reward for a directional long trade. Valuation looks stretched on trailing EPS but the market cap ($654M) and enterprise value (~…
Energy Fuels (UUUU) has pivoted from a pure uranium play into a vertically integrated rare earths and magnet strategy. The $1.9B Vacuumschmelze acquisition, a conditional $725M DoD loan commitment, and imminent commercial REE oxide production at White Mesa materially change the risk profile. We view the stock as a long-term trade: enter $11.36, tar…
Alphabet's share price has pulled back from spring highs, but recent results and product monetization point to durable earnings power. With Google Cloud accelerating and multiple AI monetization levers available, the current level is a compelling entry for long-term investors who can withstand interim volatility. Trade plan includes a clear entry a…
Dorchester Minerals (DMLP) just announced a large Q2 cash distribution that, when annualized, implies a forward yield near 18.9% on today’s $27 share price. The distribution is backed by robust quarterly cash receipts and strong free cash flow, making DMLP an attractive income trade for investors comfortable with commodity-linked royalty exposure. …
Waste Connections (WCN) is a cash-generative solid-waste operator with durable pricing, a growing RNG footprint and room to compress multiples as free cash flow accelerates. This trade proposes a long position with a clear entry, stop and target over a 180-trading-day horizon.
Lyft's operational rebound and stronger free cash flow have already driven a meaningful bounce in the stock. The business is cheaper than most expect on trailing metrics, but the market wants evidence that profitability and durable unit economics will scale before multiples expand. This idea lays out a defined long trade with entry, stop, target, a…
Intel is re-emerging as a credible AI-inference supplier and foundry player. Recent results show accelerating revenue (Q2 sales up 25% YoY to $16.1B) and improving margins, but the stock has pulled back enough to offer a risk/reward favorable to buyers. This trade targets recovery of multiple expansion and continued AI-driven revenue gains with cle…
LYTENAVA sits at a classic biotech crossroads: potential FDA approval that could re-rate the stock versus near-term cash needs that could force dilution. We recommend a Hold. For traders, a tightly risk-managed swing trade is outlined for those who want to play binary upside without being exposed to unlimited downside.
